Interviews | Page 2

advantages-of-novel-oral-anticoagulants-over-vitamin-k-antagonists
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the advantage of novel oral anticoagulants over vitamin K antagonists.
how-technology-is-changing-the-inhaler-industry
Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses how new technology is changing the inhaler manufacturing industry.
disadvantages-of-novel-oral-anticoagulants-compared-with-vitamin-k-antagonists
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the disadvantages of novel oral anticoagulants over vitamin K antagonists.
guidelines-pharmacists-should-refer-to-when-selecting-a-novel-oral-anticoagulant
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about what clinical guidelines pharmacists should refer to when selecting a novel oral anticoagulant.
why-proper-technique-is-so-important-for-inhalation-devices
Dennis Williams, PharmD, FAPhA, discusses why it's so important to use proper technique for intranasal steroids.
which-allergic-rhinitis-clinical-situations-can-be-managed-with-nonpharmacologic-treatment-options
Dennis Williams, PharmD, FAPhA, discusses which clinical situations can be managed by nonpharmacological treatments.
important-patient-factors-pharmacists-should-consider-when-selecting-inhalers
Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, discusses some important patient-related factors to consider when selecting among available inhalers.
new-trends-in-afib-management
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses new trends pharmacists should know about atrial fibrillation management.
how-should-patients-use-inhaler-devices
Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, demonstrates proper technique for inhaler devices.
pharmacotherapy-and-immunotherapy-options-for-allergic-rhinitis
Dennis Williams, PharmD, FAPhA, discusses the existing pharmacotherapy and immunotherapy options for managing allergic rhinitis.
$AD300x250BB$
Latest Issues
$auto_registration$